Regen BioPharma, Inc. (RGBP) 0.088+0.014 (+18.92%) Regen BioPharma Inc. Chairman Discusses the Rationale for Pursuing Autoimmune Indications by Activating the Nuclear Receptor NR2F6 https://finance.yahoo.com/news/regen-biopharma-inc-chairman-discusses-210100342.html?soc_src=social-sh&soc_trk=tw via @YahooFinance @frontpagestocks #TeamFPS